Instituto Grifols S.A.
4 products tracked · names used in filings: Instituto Grifols S.A., Instituto Grifols, S.A.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Veraseal human fibrinogen;human thrombin | Application withdrawn | |
| 🇪🇺 | Tavlesse fostamatinib | Authorised | 2020-01-09 |
| 🇪🇺 | VeraSeal human fibrinogen;human thrombin | Authorised | 2017-11-10 |
| 🇪🇺 | Flebogamma DIF (previously Flebogammadif) human normal immunoglobulin | Authorised | 2007-07-23 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.